Interferon Beta Drives Therapy Resistance in a Patient Derived Model of High Grade Serous Ovarian Cancer
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V.S.S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline S. Coats, Gary Yu, Yevgeniya Ioffe, Christian Hurtz, Juli Unternaehrer
This study shows that IFN-beta drives therapy resistance in HGSOC models through cell-autonomous signaling, independent of DNA damage.
Molecular Oncology · Jul 10, 2026Peer-reviewedCancer Biology